Komal Meswani

US Court rejects Wyeth’s plea to suspend USFDA approval for Zosyn generic to Orchid

by

Pharma major, Orchid Chemicals & Pharmaceuticals has got some relief from the US District Court in the legal tussle with the multinational pharma major, Wyeth Pharmaceutical

The US District Court for the District of Columbia has denied Wyeth Pharmaceutical’s motion for a Temporary Restraining Order (TRO) which was filed on Wednesday in connection with its lawsuit against the US Food and Drug Administration (US FDA) challenging the latter’s approval of Orchid’s Abbreviated New Drug Applications (ANDAs) for its Zosyn generic products Piperacillin and Tazobactam for injections.

Read moreUS Court rejects Wyeth’s plea to suspend USFDA approval for Zosyn generic to Orchid

MTS INDIA Doubles its subscriber base from 1 million in just over 3 months

by

MTS India – Sistema Shyam TeleServices Ltd has doubled its customer base from 1 mn to over 2 mn in just 3 months. MTS operating on the CDMa platform is well known for introducing disruptive tariffs in India.

Mr. Vsevolod Rozanov, President and CEO of Sistema Shyam TeleServices Limited told us,

Read moreMTS INDIA Doubles its subscriber base from 1 million in just over 3 months

Tata Rock’n’Roll with GSM operations – DoCoMO

by

Tata Teleservices (Tata) steals the show in August 2009: Tata’s net additions picked up in August 2009 to 3.4m subscribers, up 227% YoY and 52% MoM. Launch of GSM services in select circles (where spectrum was made available) have resulted in this strong jump. Tata’s have launched GSM operations in Mumbai and Maharashtra on August 6, 2009. Based on the initial feedback from our dealers, the response to the per second pulse rate billing offered by the company is positive.

Read moreTata Rock’n’Roll with GSM operations – DoCoMO

Wyeth files case against Orchid for Piperacillin, Tazobactam

by

Multinational pharmaceutical major Wyeth has filed a suit in the US District Court of Columbia against the USFDA relating to the agency’s approval of Orchid’s ANDAs for its generic products — Piperacillin and Tazobactam — for injections and also against the FDA’s decision on Wyeth’s Citizen Petition. Orchid, in a filing with the BSE, stated … Read more Wyeth files case against Orchid for Piperacillin, Tazobactam

National Stock Exchange Removes Pipavav Shipyard Book Building Link

by

The National Stock Exchange of India has removed the link for ongoing IPO of Pipavav Shipyard which indicates the current book building position. NSE is supposed to host a Link to Ongoing IPOs and provide Live Book Building Status to all the Investors of India. Here is evidence about NSE taking off Pipavav Shipyard’s Book … Read more National Stock Exchange Removes Pipavav Shipyard Book Building Link